{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:17:21Z","timestamp":1762604241736,"version":"3.37.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010426","name":"University Grants Commission India | UGC-DAE&amp;#x00A0;Consortium for Scientific Research, University Grants Commission","doi-asserted-by":"publisher","award":["326237"],"award-info":[{"award-number":["326237"]}],"id":[{"id":"10.13039\/501100010426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Travel funding from the host institute, Jawaharlal Nehru Centre for Advanced Scientific Research."},{"name":"funding from the host institute, Jawaharlal Nehru Centre for Advanced Scientific Research"},{"name":"Funding from Jawaharlal Nehru Centre for Advanced Scientific Research, and DST-SERB"},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2015\/001946"],"award-info":[{"award-number":["EMR\/2015\/001946"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["500159-Z-09-Z"],"award-info":[{"award-number":["500159-Z-09-Z"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research"},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["LSRET-JNC-00137"],"award-info":[{"award-number":["LSRET-JNC-00137"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/004795; 2018-2021"],"award-info":[{"award-number":["EMR\/2016\/004795; 2018-2021"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/YS\/LS-215\/2013; 2014-2017"],"award-info":[{"award-number":["SB\/YS\/LS-215\/2013; 2014-2017"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural funding from the host institute, Jawaharlal Nehru Centre for Advanced Scientific Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maintenance of cellular proteostasis is vital for post-mitotic cells like neurons to sustain normal physiological function and homeostasis, defects in which are established hallmarks of several age-related conditions like AD, PD, HD, and ALS. The Spatio-temporal accumulation of aggregated proteins in the form of inclusion bodies\/plaques is one of the major characteristics of many neurodegenerative diseases, including Huntington\u2019s disease (HD). Toxic accumulation of HUNTINGTIN (HTT) aggregates in neurons bring about the aberrant phenotypes of HD, including severe motor dysfunction, dementia, and cognitive impairment at the organismal level, in an age-dependent manner. In several cellular and animal models, aggrephagy induction has been shown to clear aggregate-prone proteins like HTT and ameliorate disease pathology by conferring neuroprotection. In this study, we used the mouse model of HD, R6\/2, to understand the pathogenicity of mHTT aggregates, primarily focusing on autophagy dysfunction. We report that basal autophagy is not altered in R6\/2 mice, whilst being functional at a steady-state level in neurons. Moreover, we tested the efficacy of a known autophagy modulator, Nilotinib (Tasigna\u2122), presently in clinical trials for PD, and HD, in curbing mHTT aggregate growth and their potential clearance, which was ineffective in both inducing autophagy and rescuing the pathological phenotypes in R6\/2 mice.<\/jats:p>","DOI":"10.1038\/s41598-020-78850-w","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T11:13:01Z","timestamp":1610104381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Spatiotemporal analysis of soluble aggregates and autophagy markers in the R6\/2 mouse model"],"prefix":"10.1038","volume":"11","author":[{"given":"M. J. Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devanshi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridhula","family":"Giridharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0923-5485","authenticated-orcid":false,"given":"Ravi","family":"Manjithaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-6430","authenticated-orcid":false,"given":"James P.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"78850_CR1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting proteostasis for disease intervention. Science 319, 916\u2013919. https:\/\/doi.org\/10.1126\/science.1141448 (2008).","journal-title":"Science"},{"key":"78850_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg, A. L. Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895\u2013899. https:\/\/doi.org\/10.1038\/nature02263 (2003).","journal-title":"Nature"},{"key":"78850_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2010.11.003","volume":"238","author":"DJ Metcalf","year":"2012","unstructured":"Metcalf, D. J., Garcia-Arencibia, M., Hochfeld, W. E. & Rubinsztein, D. C. Autophagy and misfolded proteins in neurodegeneration. Exp. Neurol. 238, 22\u201328. https:\/\/doi.org\/10.1016\/j.expneurol.2010.11.003 (2012).","journal-title":"Exp. Neurol."},{"key":"78850_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrd2272","volume":"6","author":"DC Rubinsztein","year":"2007","unstructured":"Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O. & Klionsky, D. J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6, 304\u2013312. https:\/\/doi.org\/10.1038\/nrd2272 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"78850_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997. https:\/\/doi.org\/10.1038\/nm.3232 (2013).","journal-title":"Nat. Med."},{"key":"78850_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrn3961","volume":"16","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M., Fleming, A. & Rubinsztein, D. C. Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16, 345\u2013357. https:\/\/doi.org\/10.1038\/nrn3961 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"78850_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/B978-0-12-385883-2.00003-5","volume":"107","author":"JE Gestwicki","year":"2012","unstructured":"Gestwicki, J. E. & Garza, D. Protein quality control in neurodegenerative disease. Prog. Mol. Biol. Transl. Sci. 107, 327\u2013353. https:\/\/doi.org\/10.1016\/B978-0-12-385883-2.00003-5 (2012).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"78850_CR8","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2017.1302045","volume":"13","author":"SN Suresh","year":"2017","unstructured":"Suresh, S. N. et al. A novel autophagy modulator 6-Bio ameliorates SNCA\/alpha-synuclein toxicity. Autophagy 13, 1221\u20131234. https:\/\/doi.org\/10.1080\/15548627.2017.1302045 (2017).","journal-title":"Autophagy"},{"key":"78850_CR9","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738 (2004).","journal-title":"Science"},{"key":"78850_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","volume":"13","author":"M Martinez-Vicente","year":"2010","unstructured":"Martinez-Vicente, M. et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease. Nat. Neurosci. 13, 567\u2013576. https:\/\/doi.org\/10.1038\/nn.2528 (2010).","journal-title":"Nat. Neurosci."},{"key":"78850_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature04724","volume":"441","author":"T Hara","year":"2006","unstructured":"Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885\u2013889. https:\/\/doi.org\/10.1038\/nature04724 (2006).","journal-title":"Nature"},{"key":"78850_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880\u2013884. https:\/\/doi.org\/10.1038\/nature04723 (2006).","journal-title":"Nature"},{"key":"78850_CR13","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/ncomms3300","volume":"4","author":"JO Pyo","year":"2013","unstructured":"Pyo, J. O. et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 4, 2300. https:\/\/doi.org\/10.1038\/ncomms3300 (2013).","journal-title":"Nat. Commun."},{"key":"78850_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.devcel.2016.09.001","volume":"39","author":"SR Yoshii","year":"2016","unstructured":"Yoshii, S. R. et al. Systemic analysis of Atg5-null mice rescued from neonatal lethality by transgenic ATG5 expression in neurons. Dev. Cell 39, 116\u2013130 (2016).","journal-title":"Dev. Cell"},{"key":"78850_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-018-0162-7","volume":"558","author":"\u00c1F Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez, \u00c1. F. et al. Disruption of the beclin 1\u2013BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558, 136\u2013140 (2018).","journal-title":"Nature"},{"key":"78850_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13540-4","volume":"10","author":"C Kumsta","year":"2019","unstructured":"Kumsta, C. et al. The autophagy receptor p62\/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy. Nat. Commun. 10, 1\u201312 (2019).","journal-title":"Nat. Commun."},{"key":"78850_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","volume":"117","author":"C Vidoni","year":"2018","unstructured":"Vidoni, C., Secomandi, E., Castiglioni, A., Melone, M. A. & Isidoro, C. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem. Int. 117, 174\u2013187 (2018).","journal-title":"Neurochem. Int."},{"key":"78850_CR18","doi-asserted-by":"publisher","first-page":"e0120819","DOI":"10.1371\/journal.pone.0120819","volume":"10","author":"K Kilpatrick","year":"2015","unstructured":"Kilpatrick, K., Zeng, Y., Hancock, T. & Segatori, L. Genetic and chemical activation of TFEB mediates clearance of aggregated \u03b1-synuclein. PLoS ONE 10, e0120819 (2015).","journal-title":"PLoS ONE"},{"key":"78850_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds. Nature 575, 203\u2013209 (2019).","journal-title":"Nature"},{"key":"78850_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41580-018-0033-y","volume":"19","author":"M Hansen","year":"2018","unstructured":"Hansen, M., Rubinsztein, D. C. & Walker, D. W. Autophagy as a promoter of longevity: insights from model organisms. Nat. Rev. Mol. Cell Biol. 19, 579\u2013593. https:\/\/doi.org\/10.1038\/s41580-018-0033-y (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"78850_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jmg.30.12.982","volume":"30","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease. J. Med. Genet. 30, 982\u2013986 (1993).","journal-title":"J. Med. Genet."},{"key":"78850_CR22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1176\/ajp.154.8.1046","volume":"154","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. Clinical genetics, II. Huntington\u2019s disease: from the gene to pathophysiology. Am. J. Psychiatry 154, 1046. https:\/\/doi.org\/10.1176\/ajp.154.8.1046 (1997).","journal-title":"Am. J. Psychiatry"},{"key":"78850_CR23","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","volume":"16","author":"PG Bhide","year":"1996","unstructured":"Bhide, P. G. et al. Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 16, 5523\u20135535 (1996).","journal-title":"J. Neurosci."},{"key":"78850_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies, S. W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537\u2013548 (1997).","journal-title":"Cell"},{"key":"78850_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel, J. P. & DiFiglia, M. Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369\u2013384 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"78850_CR26","unstructured":"Caron, N. S., Wright, G. E. B. & Hayden, M. R. in GeneReviews((R)) (eds M. P. Adam et al.) (1993)."},{"key":"78850_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.410420411","volume":"42","author":"E Sapp","year":"1997","unstructured":"Sapp, E. et al. Huntingtin localization in brains of normal and Huntington\u2019s disease patients. Ann. Neurol. 42, 604\u2013612. https:\/\/doi.org\/10.1002\/ana.410420411 (1997).","journal-title":"Ann. Neurol."},{"key":"78850_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li, J. Y., Popovic, N. & Brundin, P. The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies. NeuroRx 2, 447\u2013464. https:\/\/doi.org\/10.1602\/neurorx.2.3.447 (2005).","journal-title":"NeuroRx"},{"key":"78850_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"78850_CR30","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","volume":"22","author":"ML Hebron","year":"2013","unstructured":"Hebron, M. L., Lonskaya, I. & Moussa, C. E. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in Parkinson\u2019s disease models. Hum. Mol. Genet. 22, 3315\u20133328. https:\/\/doi.org\/10.1093\/hmg\/ddt192 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR31","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1038\/srep04874","volume":"4","author":"SS Karuppagounder","year":"2014","unstructured":"Karuppagounder, S. S. et al. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson\u2019s disease. Sci. Rep. 4, 4874. https:\/\/doi.org\/10.1038\/srep04874 (2014).","journal-title":"Sci. Rep."},{"key":"78850_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan, F. et al. Nilotinib effects in Parkinson\u2019s disease and dementia with Lewy bodies. J. Parkinson\u2019s Dis. 6, 503\u2013517 (2016).","journal-title":"J. Parkinson's Dis."},{"key":"78850_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. & Aguilar, L. G. Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatr. Dis. Treat. 4, 743 (2008).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"78850_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3233\/JHD-190001","volume":"8","author":"FB Rodrigues","year":"2019","unstructured":"Rodrigues, F. B., Quinn, L. & Wild, E. J. Huntington\u2019s disease clinical trials corner: January 2019. J. Huntington\u2019s Dis. 8, 115\u2013125 (2019).","journal-title":"J. Huntington's Dis."},{"key":"78850_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JHD-199003","volume":"8","author":"FB Rodrigues","year":"2019","unstructured":"Rodrigues, F. B., Ferreira, J. J. & Wild, E. J. Huntington\u2019s disease clinical trials corner: June 2019. J. Huntington\u2019s Dis. 8, 363\u2013371 (2019).","journal-title":"J. Huntington's Dis."},{"key":"78850_CR36","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates, G. Huntingtin aggregation and toxicity in Huntington\u2019s disease. Lancet 361, 1642\u20131644. https:\/\/doi.org\/10.1016\/S0140-6736(03)13304-1 (2003).","journal-title":"Lancet"},{"key":"78850_CR37","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993. https:\/\/doi.org\/10.1126\/science.277.5334.1990 (1997).","journal-title":"Science"},{"key":"78850_CR38","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang, C. E. et al. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease. Hum. Mol. Genet. 17, 2738\u20132751. https:\/\/doi.org\/10.1093\/hmg\/ddn175 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack, E. C. et al. Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice. J. Comp. Neurol. 490, 354\u2013370. https:\/\/doi.org\/10.1002\/cne.20680 (2005).","journal-title":"J. Comp. Neurol."},{"key":"78850_CR40","doi-asserted-by":"crossref","unstructured":"Landles, C. et al. Subcellular localisation and formation of huntingtin aggregates correlates with symptom onset and progression in a Huntington's disease model. Brain Commun. fcaa066 (2020).","DOI":"10.1093\/braincomms\/fcaa066"},{"key":"78850_CR41","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.celrep.2017.10.097","volume":"21","author":"F Hosp","year":"2017","unstructured":"Hosp, F. et al. Spatiotemporal proteomic profiling of Huntington\u2019s disease inclusions reveals widespread loss of protein function. Cell Rep. 21, 2291\u20132303 (2017).","journal-title":"Cell Rep."},{"key":"78850_CR42","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.1530212100","volume":"100","author":"KM Donaldson","year":"2003","unstructured":"Donaldson, K. M. et al. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 100, 8892\u20138897. https:\/\/doi.org\/10.1073\/pnas.1530212100 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78850_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41598-018-19538-0","volume":"8","author":"K Juenemann","year":"2018","unstructured":"Juenemann, K. et al. Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies. Sci. Rep. 8, 1405. https:\/\/doi.org\/10.1038\/s41598-018-19538-0 (2018).","journal-title":"Sci. Rep."},{"key":"78850_CR44","doi-asserted-by":"publisher","first-page":"e41450","DOI":"10.1371\/journal.pone.0041450","volume":"7","author":"B Gong","year":"2012","unstructured":"Gong, B., Kielar, C. & Morton, A. J. Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington\u2019s disease mutation. PLoS ONE 7, e41450. https:\/\/doi.org\/10.1371\/journal.pone.0041450 (2012).","journal-title":"PLoS ONE"},{"key":"78850_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2015.00001","volume":"8","author":"K Juenemann","year":"2015","unstructured":"Juenemann, K., Wiemhoefer, A. & Reits, E. A. Detection of ubiquitinated huntingtin species in intracellular aggregates. Front. Mol. Neurosci. 8, 1. https:\/\/doi.org\/10.3389\/fnmol.2015.00001 (2015).","journal-title":"Front. Mol. Neurosci."},{"key":"78850_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells6030025","author":"I Benito-Cuesta","year":"2017","unstructured":"Benito-Cuesta, I., Diez, H., Ordonez, L. & Wandosell, F. Assessment of autophagy in neurons and brain tissue. Cells https:\/\/doi.org\/10.3390\/cells6030025 (2017).","journal-title":"Cells"},{"key":"78850_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.conb.2018.02.008","volume":"51","author":"A Kulkarni","year":"2018","unstructured":"Kulkarni, A., Chen, J. & Maday, S. Neuronal autophagy and intercellular regulation of homeostasis in the brain. Curr. Opin. Neurobiol. 51, 29\u201336. https:\/\/doi.org\/10.1016\/j.conb.2018.02.008 (2018).","journal-title":"Curr. Opin. Neurobiol."},{"key":"78850_CR48","doi-asserted-by":"publisher","first-page":"e83050","DOI":"10.1371\/journal.pone.0083050","volume":"8","author":"B Baldo","year":"2013","unstructured":"Baldo, B., Soylu, R. & Petersen, A. Maintenance of basal levels of autophagy in Huntington\u2019s disease mouse models displaying metabolic dysfunction. PLoS ONE 8, e83050. https:\/\/doi.org\/10.1371\/journal.pone.0083050 (2013).","journal-title":"PLoS ONE"},{"key":"78850_CR49","doi-asserted-by":"publisher","first-page":"18249","DOI":"10.1074\/jbc.M112.446385","volume":"288","author":"H-C Yu","year":"2013","unstructured":"Yu, H.-C. et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J. Biol. Chem. 288, 18249\u201318259 (2013).","journal-title":"J. Biol. Chem."},{"key":"78850_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/cells8050506","volume":"8","author":"T Hussain","year":"2019","unstructured":"Hussain, T. et al. Nilotinib: a tyrosine kinase inhibitor mediates resistance to intracellular Mycobacterium via regulating autophagy. Cells 8, 506 (2019).","journal-title":"Cells"},{"key":"78850_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","volume":"92","author":"I Lonskaya","year":"2014","unstructured":"Lonskaya, I., Hebron, M. L., Desforges, N. M., Schachter, J. B. & Moussa, C. E. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance. J. Mol. Med. 92, 373\u2013386 (2014).","journal-title":"J. Mol. Med."},{"key":"78850_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo, A. et al. Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease. Sci. Rep. 7, 1\u20138 (2017).","journal-title":"Sci. Rep."},{"key":"78850_CR53","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter, R. J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J. Neurosci. 19, 3248\u20133257 (1999).","journal-title":"J. Neurosci."},{"key":"78850_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp, M. S., Park, S. H. & Hartl, F. U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 24, 506\u2013514. https:\/\/doi.org\/10.1016\/j.tcb.2014.05.003 (2014).","journal-title":"Trends Cell Biol."},{"key":"78850_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jnc.13575","volume":"137","author":"JJ Yerbury","year":"2016","unstructured":"Yerbury, J. J. et al. Walking the tightrope: proteostasis and neurodegenerative disease. J. Neurochem. 137, 489\u2013505. https:\/\/doi.org\/10.1111\/jnc.13575 (2016).","journal-title":"J. Neurochem."},{"key":"78850_CR56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107\u20131117 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR57","doi-asserted-by":"publisher","first-page":"736905","DOI":"10.1155\/2012\/736905","volume":"2012","author":"T Lamark","year":"2012","unstructured":"Lamark, T. & Johansen, T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 736905. https:\/\/doi.org\/10.1155\/2012\/736905 (2012).","journal-title":"Int. J. Cell Biol."},{"key":"78850_CR58","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba, J. et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. 111, 16889\u201316894 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"78850_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DD Martin","year":"2015","unstructured":"Martin, D. D., Ladha, S., Ehrnhoefer, D. E. & Hayden, M. R. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 38, 26\u201335. https:\/\/doi.org\/10.1016\/j.tins.2014.09.003 (2015).","journal-title":"Trends Neurosci."},{"key":"78850_CR60","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15548627.2015.1039219","volume":"11","author":"Y-N Rui","year":"2015","unstructured":"Rui, Y.-N., Xu, Z., Patel, B., Cuervo, A. M. & Zhang, S. HTT\/Huntingtin in selective autophagy and Huntington disease: a foe or a friend within?. Autophagy 11, 858\u2013860 (2015).","journal-title":"Autophagy"},{"key":"78850_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.conb.2017.10.019","volume":"48","author":"MB Veldman","year":"2018","unstructured":"Veldman, M. B. & Yang, X. W. Molecular insights into cortico-striatal miscommunications in Huntington\u2019s disease. Curr. Opin. Neurobiol. 48, 79\u201389. https:\/\/doi.org\/10.1016\/j.conb.2017.10.019 (2018).","journal-title":"Curr. Opin. Neurobiol."},{"key":"78850_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnhum.2016.00317","volume":"10","author":"KD Bunner","year":"2016","unstructured":"Bunner, K. D. & Rebec, G. V. Corticostriatal dysfunction in huntington\u2019s disease: the basics. Front. Hum. Neurosci. 10, 317. https:\/\/doi.org\/10.3389\/fnhum.2016.00317 (2016).","journal-title":"Front. Hum. Neurosci."},{"key":"78850_CR63","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","volume":"129","author":"M Akutsu","year":"2016","unstructured":"Akutsu, M., Dikic, I. & Bremm, A. Ubiquitin chain diversity at a glance. J. Cell Sci. 129, 875\u2013880. https:\/\/doi.org\/10.1242\/jcs.183954 (2016).","journal-title":"J. Cell Sci."},{"key":"78850_CR64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molcel.2016.07.022","volume":"63","author":"YE Kim","year":"2016","unstructured":"Kim, Y. E. et al. Soluble oligomers of PolyQ-expanded huntingtin target a multiplicity of key cellular factors. Mol. Cell 63, 951\u2013964 (2016).","journal-title":"Mol. Cell"},{"key":"78850_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34916","volume":"6","author":"W Xi","year":"2016","unstructured":"Xi, W., Wang, X., Laue, T. M. & Denis, C. L. Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington\u2019s disease model system. Sci. Rep. 6, 1\u201314 (2016).","journal-title":"Sci. Rep."},{"key":"78850_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman, J., Hartl, F. U. & Lederkremer, G. Z. Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat. Commun. 4, 1\u201310 (2013).","journal-title":"Nat. Commun."},{"key":"78850_CR67","doi-asserted-by":"publisher","first-page":"e15245","DOI":"10.1371\/journal.pone.0015245","volume":"5","author":"P Lajoie","year":"2010","unstructured":"Lajoie, P. & Snapp, E. L. Formation and toxicity of soluble polyglutamine oligomers in living cells. PLoS ONE 5, e15245 (2010).","journal-title":"PLoS ONE"},{"key":"78850_CR68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/ddm311","volume":"17","author":"T Takahashi","year":"2008","unstructured":"Takahashi, T. et al. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum. Mol. Genet. 17, 345\u2013356 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y Nagai","year":"2007","unstructured":"Nagai, Y. et al. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332\u2013340 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"78850_CR70","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805\u2013810 (2004).","journal-title":"Nature"},{"key":"78850_CR71","first-page":"1","volume":"5","author":"C-S Sun","year":"2015","unstructured":"Sun, C.-S. et al. Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect. Sci. Rep. 5, 1\u201313 (2015).","journal-title":"Sci. Rep."},{"key":"78850_CR72","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1474-4422(04)00921-4","volume":"3","author":"A Burton","year":"2004","unstructured":"Burton, A. Inclusion bodies may be neuroprotective in Huntington\u2019s disease. Lancet Neurol. 3, 699 (2004).","journal-title":"Lancet Neurol."},{"key":"78850_CR73","doi-asserted-by":"crossref","unstructured":"Albin, R. L. Polyglutamine inclusion body toxicity. (2017).","DOI":"10.1002\/mds.27226"},{"key":"78850_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/jmcb\/mjq005","volume":"2","author":"T Takahashi","year":"2010","unstructured":"Takahashi, T., Katada, S. & Onodera, O. Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going?. J. Mol. Cell Biol. 2, 180\u2013191 (2010).","journal-title":"J. Mol. Cell Biol."},{"key":"78850_CR75","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1038\/cddis.2012.121","volume":"3","author":"G Cisbani","year":"2012","unstructured":"Cisbani, G. & Cicchetti, F. An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis. 3, e382\u2013e382 (2012).","journal-title":"Cell Death Dis."},{"key":"78850_CR76","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/srep00895","volume":"2","author":"SJ Sahl","year":"2012","unstructured":"Sahl, S. J., Weiss, L. E., Duim, W. C., Frydman, J. & Moerner, W. Cellular inclusion bodies of mutant huntingtin exon 1 obscure small fibrillar aggregate species. Sci. Rep. 2, 895 (2012).","journal-title":"Sci. Rep."},{"key":"78850_CR77","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","volume":"6","author":"S Engelender","year":"1997","unstructured":"Engelender, S. et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6, 2205\u20132212 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR78","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926. https:\/\/doi.org\/10.1016\/j.neuron.2016.02.003 (2016).","journal-title":"Neuron"},{"key":"78850_CR79","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes, P. & Wanker, E. E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28, 425\u2013433. https:\/\/doi.org\/10.1016\/S0968-0004(03)00168-3 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"78850_CR80","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo, E., Zuccato, C. & Tartari, M. Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat. Rev. Neurosci. 6, 919\u2013930. https:\/\/doi.org\/10.1038\/nrn1806 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"78850_CR81","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges, A. et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum. Mol. Genet. 15, 965\u2013977 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR82","doi-asserted-by":"publisher","first-page":"e83050","DOI":"10.1371\/journal.pone.0083050","volume":"8","author":"B Baldo","year":"2013","unstructured":"Baldo, B., Soylu, R. & Peters\u00e9n, \u00c5. Maintenance of basal levels of autophagy in Huntington\u2019s disease mouse models displaying metabolic dysfunction. PLoS ONE 8, e83050 (2013).","journal-title":"PLoS ONE"},{"key":"78850_CR83","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ng0604-553","volume":"36","author":"CC Thoreen","year":"2004","unstructured":"Thoreen, C. C. & Sabatini, D. M. Huntingtin aggregates ask to be eaten. Nat. Genet. 36, 553\u2013554. https:\/\/doi.org\/10.1038\/ng0604-553 (2004).","journal-title":"Nat. Genet."},{"key":"78850_CR84","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1111\/febs.13722","volume":"283","author":"H Yang","year":"2016","unstructured":"Yang, H. & Hu, H. Y. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology. FEBS J. 283, 3705\u20133717. https:\/\/doi.org\/10.1111\/febs.13722 (2016).","journal-title":"FEBS J."},{"key":"78850_CR85","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1523\/JNEUROSCI.1409-03.2004","volume":"24","author":"ZH Qin","year":"2004","unstructured":"Qin, Z. H. et al. Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J. Neurosci. 24, 269\u2013281. https:\/\/doi.org\/10.1523\/JNEUROSCI.1409-03.2004 (2004).","journal-title":"J. Neurosci."},{"key":"78850_CR86","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1073\/pnas.1004498107","volume":"107","author":"AS Tsvetkov","year":"2010","unstructured":"Tsvetkov, A. S. et al. A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc. Natl. Acad. Sci. USA 107, 16982\u201316987. https:\/\/doi.org\/10.1073\/pnas.1004498107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78850_CR87","doi-asserted-by":"publisher","first-page":"16685","DOI":"10.1073\/pnas.0707842104","volume":"104","author":"V Chopra","year":"2007","unstructured":"Chopra, V. et al. A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2\u20138 in the R6\/2 transgenic mouse. Proc. Natl. Acad. Sci. USA 104, 16685\u201316689. https:\/\/doi.org\/10.1073\/pnas.0707842104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78850_CR88","doi-asserted-by":"publisher","first-page":"e87513","DOI":"10.1371\/journal.pone.0087513","volume":"9","author":"N Safren","year":"2014","unstructured":"Safren, N. et al. Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 9, e87513. https:\/\/doi.org\/10.1371\/journal.pone.0087513 (2014).","journal-title":"PLoS ONE"},{"key":"78850_CR89","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154. https:\/\/doi.org\/10.1038\/nm985 (2004).","journal-title":"Nat. Med."},{"key":"78850_CR90","doi-asserted-by":"publisher","first-page":"18492","DOI":"10.1523\/JNEUROSCI.3219-11.2011","volume":"31","author":"H Koga","year":"2011","unstructured":"Koga, H. et al. Constitutive upregulation of chaperone-mediated autophagy in Huntington\u2019s disease. J. Neurosci. 31, 18492\u201318505. https:\/\/doi.org\/10.1523\/JNEUROSCI.3219-11.2011 (2011).","journal-title":"J. Neurosci."},{"key":"78850_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnmol.2018.00109","volume":"11","author":"SN Suresh","year":"2018","unstructured":"Suresh, S. N. et al. Modulation of autophagy by a small molecule inverse agonist of ERRalpha is neuroprotective. Front. Mol. Neurosci. 11, 109. https:\/\/doi.org\/10.3389\/fnmol.2018.00109 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"78850_CR92","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","volume":"126","author":"HG Luesse","year":"2001","unstructured":"Luesse, H. G. et al. Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus. Behav. Brain Res. 126, 185\u2013195 (2001).","journal-title":"Behav. Brain Res."},{"key":"78850_CR93","doi-asserted-by":"publisher","first-page":"18249","DOI":"10.1074\/jbc.M112.446385","volume":"288","author":"HC Yu","year":"2013","unstructured":"Yu, H. C. et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J. Biol. Chem. 288, 18249\u201318259. https:\/\/doi.org\/10.1074\/jbc.M112.446385 (2013).","journal-title":"J. Biol. Chem."},{"key":"78850_CR94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan, F. et al. Nilotinib effects in Parkinson\u2019s disease and Dementia with Lewy bodies. J. Parkinsons Dis. 6, 503\u2013517. https:\/\/doi.org\/10.3233\/JPD-160867 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"78850_CR95","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","volume":"92","author":"I Lonskaya","year":"2014","unstructured":"Lonskaya, I., Hebron, M. L., Desforges, N. M., Schachter, J. B. & Moussa, C. E. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance. J. Mol. Med. (Berl) 92, 373\u2013386. https:\/\/doi.org\/10.1007\/s00109-013-1112-3 (2014).","journal-title":"J. Mol. Med. (Berl)"},{"key":"78850_CR96","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","volume":"22","author":"ML Hebron","year":"2013","unstructured":"Hebron, M. L., Lonskaya, I. & Moussa, C.E.-H. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of \u03b1-synuclein in Parkinson\u2019s disease models. Hum. Mol. Genet. 22, 3315\u20133328 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"78850_CR97","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi, M. A., Morton, A. J. & Hayden, M. R. Choosing an animal model for the study of Huntington\u2019s disease. Nat. Rev. Neurosci. 14, 708\u2013721. https:\/\/doi.org\/10.1038\/nrn3570 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"78850_CR98","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","volume":"23","author":"LB Menalled","year":"2002","unstructured":"Menalled, L. B. & Chesselet, M. F. Mouse models of Huntington\u2019s disease. Trends Pharmacol. Sci. 23, 32\u201339 (2002).","journal-title":"Trends Pharmacol. Sci."},{"key":"78850_CR99","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante, R. J. Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 1792, 506\u2013520. https:\/\/doi.org\/10.1016\/j.bbadis.2009.04.001 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"78850_CR100","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1242\/dmm.002451","volume":"2","author":"DE Ehrnhoefer","year":"2009","unstructured":"Ehrnhoefer, D. E., Butland, S. L., Pouladi, M. A. & Hayden, M. R. Mouse models of Huntington disease: variations on a theme. Dis. Model Mech. 2, 123\u2013129. https:\/\/doi.org\/10.1242\/dmm.002451 (2009).","journal-title":"Dis. Model Mech."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78850-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:11:24Z","timestamp":1674814284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78850-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["78850"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78850-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}